Robeco Institutional Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Robeco Institutional Asset Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-7,765	Closed	-$425K	–	975
2020 Q3	$425K	Hold	7,765	–	–	﹤0.01%	769
2020 Q2	$516K	Sell	7,765 -8,221	-51%	-$551K	﹤0.01%	806
2020 Q1	$979K	Hold	15,986	–	–	﹤0.01%	763
2019 Q4	$1.41M	Sell	15,986 -37,455	-70%	-$3.16M	﹤0.01%	755
2019 Q3	$4.03M	Hold	53,441	–	–	0.01%	627
2019 Q2	$4.56M	Buy	53,441 +20,002	+60%	+$1.98M	0.02%	605
2019 Q1	$3.61M	Sell	33,439 -1,266	-4%	-$126K	0.01%	631
2018 Q4	$2.94M	Sell	34,705 -1,495	-4%	-$144K	0.01%	620
2018 Q3	$3.56M	Buy	36,200 +3,030	+9%	+$328K	0.01%	607
2018 Q2	$3.84M	Buy	+33,170	New	+$3.64M	0.02%	561

Other funds holding TARO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

KAM

Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Robeco Institutional Asset Management's TARO Position: Q4 2020 in Review

Robeco Institutional Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2020, closing a stake of 7,765 shares — an estimated $425K sold.

Robeco Institutional Asset Management first reported a position in TARO in Q2 2018 and held it in 10 quarters. The position peaked at $4.56M in Q2 2019. 84 funds tracked by Wall St. Rank hold TARO as of Q4 2020.

Robeco Institutional Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2020 after selling out during the quarter.
Robeco Institutional Asset Management sold 7,765 Taro Pharmaceutical Industries Ltd. shares in Q4 2020, an estimated $425K.
Robeco Institutional Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2018 and held it in 10 quarters.
Robeco Institutional Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $4.56M in Q2 2019.
84 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2020.

Based on Robeco Institutional Asset Management's 13F filing for Q4 2020, filed 28 Jan 2021.